Ron Bentsur - Jul 7, 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
Jul 7, 2023
Transactions value $
$4,035
Form type
4
Date filed
7/18/2023, 08:34 AM
Previous filing
Jul 7, 2023
Next filing
Jul 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1.78K +110 +0% $16.19 3.23M Jul 7, 2023 Direct F1
transaction NVCT Common Stock Purchase $2.25K +150 +0% $15.03 3.23M Jul 14, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 426,759 shares of restricted stock.